National Key Research and Development Program of China#1 under Y.W.[number 2022YFC3400904];National Natural Science Foundation of China#2 under Q.Z.[number 81988101 and 81830086];National Natural Science Foundation of China#3 under Y.W.[number 82173152];Research Unit of Molecular Cancer Research,Chinese Academy of Medical Sciences,CAMS Innovation Fund for Medical Sciences#4 under Q.Z.[number 2019-I2M-5-081];Science Foundation of Peking University Cancer Hospital#5 under Q.Z.[number 17-01].
Cachexia,which affects 50–80%of cancer patients,is a debilitating syndrome that leads to 20%of cancer-related deaths.A key feature of cachexia is adipose tissue atrophy,but how it contributes to the development of ca...
This study was supported by Beijing University of Traditional Chinese Medicine Dongzhimen Hospital 2022 Science and Technology Innovation Special Project(DZMKJCX-2022-008)。
Objective:To investigate the regulatory effect of Qiliqiangxin Capsule on mitochondrial Ca^(2+)related genes in rats with myocardial infarction(MI).Methods:The rat model of MI was established by ligation of the left a...
supported by National Natural Science Foundation of China (21571006, 21771010);Beijing Municipal Science & Technology Commission (A61120-01);the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA 12040101)
Association of Alzheimer's disease(AD) with cerebral glucose hypometabolism, likely due to impairments of insulin signaling,has been reported recently, with encouraging results when additional insulin is provided to A...